Literature DB >> 31431369

Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial.

Thomas Zilli1, Ciro Franzese2, Marta Bottero3, Niccolò Giaj-Levra4, Robert Förster5, Daniel Zwahlen6, Nikolaos Koutsouvelis3, Aurelie Bertaut7, Julie Blanc7, Giuseppe Roberto D'agostino2, Filippo Alongi8, Matthias Guckenberger5, Marta Scorsetti9, Raymond Miralbell10.   

Abstract

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Monotherapy; Phase I/II trial; Prostate cancer; SBRT; Toxicity

Mesh：

Year:  2019        PMID： 31431369     DOI： 10.1016/j.radonc.2019.07.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  12 in total

1.  [Ultra-hypofractionation in localized prostate cancer. 5-year results of the HYPO-RT-PC trial: Commentary I].

Authors:  Ping Jiang; Oliver Blanck; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2019-12       Impact factor: 3.621

2.  Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection.

Authors:  Ciro Franzese; Matteo Perrino; Marco Antonio Marzo; Marco Badalamenti; Davide Baldaccini; Giuseppe D'Agostino; Beatrice Marini; Fabio De Vincenzo; Paolo Andrea Zucali; Marta Scorsetti
Journal:  Clin Exp Metastasis       Date:  2022-02-21       Impact factor: 5.150

3.  Delivery of therapeutic carbon monoxide by gas-entrapping materials.

Authors:  James D Byrne; David Gallo; Hannah Boyce; Sarah L Becker; Kristi M Kezar; Alicia T Cotoia; Vivian R Feig; Aaron Lopes; Eva Csizmadia; Maria Serena Longhi; Jung Seung Lee; Hyunjoon Kim; Adam J Wentworth; Sidharth Shankar; Ghee Rye Lee; Jianling Bi; Emily Witt; Keiko Ishida; Alison Hayward; Johannes L P Kuosmanen; Josh Jenkins; Jacob Wainer; Aya Aragon; Kaitlyn Wong; Christoph Steiger; William R Jeck; Dustin E Bosch; Mitchell C Coleman; Douglas R Spitz; Michael Tift; Robert Langer; Leo E Otterbein; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2022-06-29       Impact factor: 19.319

4.  [Virtual prostatectomy using single dose radiotherapy].

Authors:  Mohamed Shelan; Elena Riggenbach; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2021-07-23       Impact factor: 3.621

Review 5.  MR-Guided Radiotherapy for Prostate Cancer.

Authors:  Boris R Tocco; Amar U Kishan; Ting Martin Ma; Linda G W Kerkmeijer; Alison C Tree
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

6.  Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study.

Authors:  Thomas Willigenburg; Ellis Beld; Jochem Hes; Jan J W Lagendijk; Hans C J de Boer; Marinus A Moerland; Jochem R N van der Voort van Zyp
Journal:  Phys Imaging Radiat Oncol       Date:  2020-08-07

7.  HERMES: Delivery of a Speedy Prostate Cancer Treatment.

Authors:  R Westley; E Hall; A Tree
Journal:  Clin Oncol (R Coll Radiol)       Date:  2022-01-31       Impact factor: 4.925

Review 8.  Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review.

Authors:  Christina Schröder; Hongjian Tang; Paul Windisch; Daniel Rudolf Zwahlen; André Buchali; Erwin Vu; Tilman Bostel; Tanja Sprave; Thomas Zilli; Vedang Murthy; Robert Förster
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

9.  Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.

Authors:  Yosuke Takakusagi; Hiroyuki Katoh; Kio Kano; Wataru Anno; Keisuke Tsuchida; Nobutaka Mizoguchi; Itsuko Serizawa; Daisaku Yoshida; Tadashi Kamada
Journal:  Radiat Oncol       Date:  2020-05-27       Impact factor: 3.481

10.  Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.

Authors:  J Schaule; M Chamberlain; L Wilke; M Baumgartl; J Krayenbühl; M Zamburlini; M Mayinger; N Andratschke; S Tanadini-Lang; M Guckenberger
Journal:  Radiat Oncol       Date:  2021-09-26       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.